Neurocrine Bioscienc
(NBIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -141,090 | -96,431 | -59,544 | -19,264 | -88,929 |
| Depreciation Amortization | 4,973 | 4,159 | 3,040 | 1,673 | 7,041 |
| Accounts receivable | N/A | N/A | N/A | -14,577 | N/A |
| Other Working Capital | 5,781 | 565 | 1,074 | -17,034 | 8,703 |
| Other Operating Activity | 24,155 | 17,151 | 11,884 | 19,991 | 35,188 |
| Operating Cash Flow | $-106,181 | $-74,556 | $-43,546 | $-29,211 | $-37,997 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 117,050 | 101,635 | 57,662 | 71,193 | -193,929 |
| PPE Investments | -4,095 | -3,748 | -2,984 | -738 | -1,925 |
| Other Investing Activity | 0 | -92 | -79 | -200 | 40 |
| Investing Cash Flow | $112,955 | $97,795 | $54,599 | $70,255 | $-195,814 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,390 | 2,327 | 998 | 62 | 276,992 |
| Financing Cash Flow | $2,390 | $2,327 | $998 | $62 | $276,992 |
| Beginning Cash Position | 78,986 | 74,195 | 74,195 | 74,195 | 31,014 |
| End Cash Position | 88,150 | 99,761 | 86,246 | 115,301 | 74,195 |
| Net Cash Flow | $9,164 | $25,566 | $12,051 | $41,106 | $43,181 |
| Free Cash Flow | |||||
| Operating Cash Flow | -106,181 | -74,556 | -43,546 | -29,211 | -37,997 |
| Capital Expenditure | -4,108 | -3,761 | -2,984 | -741 | -1,934 |
| Free Cash Flow | -110,289 | -78,317 | -46,530 | -29,952 | -39,931 |